Urology

AI-assisted pelvic lymph node dissection improves surgeons’ ability to identify pelvic anatomy, enhancing sensitivity and specificity across specialties using artificial intelligence.

A study shows larger prostate volume is linked to lower cancer detection rates during MRI–US fusion biopsy, highlighting the need for tailored diagnostic approaches.

Single-fraction SBRT achieved promising 3-year cancer control with low toxicity in selected men with localised prostate cancer, according to a phase 1/2 trial.

New research suggests that circulating tumour cell count, in combination with prostate specific antigen levels and prostate cancer likelihood scores, may improve the diagnosis of clinically significant prostate cancer.

A clinical trial shows letrozole improves sperm concentration categories in men with spermatogenic failure. Read more on outcomes and safety findings.

Preoperative mpMRI was linked to a 10 percentage point reduction in positive surgical margins following prostatectomy, with the strongest benefit observed in pT3 disease.

Emerging evidence suggests prostate fibrosis contributes to lower urinary tract symptoms secondary to benign prostatic hyperplasia, creating opportunities for new treatments.

Antibody-drug conjugates including enfortumab vedotin and disitamab vedotin demonstrate strong efficacy in advanced urothelial carcinoma across trials and real-world settings.